Related Experiment Video
Updated: Jun 12, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Structural basis of multivalent binding to wheat germ agglutinin
David Schwefel1, Caroline Maierhofer, Johannes G Beck
1Department of Biology, Universität Konstanz, Germany.
Researchers developed multivalent N-acetylglucosamine (GlcNAc) ligands that strongly bind to wheat germ agglutinin (WGA). This study reveals how multivalent ligands enhance binding by bridging protein sites, offering a strategy for disease treatment.
Area of Science:
- Carbohydrate-protein interactions
- Glycobiology
- Structural biology
Background:
- Inhibiting carbohydrate-protein interactions with multivalent ligands is key for treating diseases.
- Understanding the molecular basis of multivalent ligand binding enhancement is crucial for effective therapeutic design.
Purpose of the Study:
- To synthesize and characterize multivalent N-acetylglucosamine (GlcNAc) derivatives.
- To investigate their binding interactions with wheat germ agglutinin (WGA).
- To elucidate the structural mechanisms behind enhanced binding affinity.
Main Methods:
- Synthesis of multivalent GlcNAc derivatives with varied linker lengths.
- Enzyme-linked lectin assay (ELLA) to determine binding potency (IC50 values).
- X-ray crystallography to analyze ligand-protein complex structures.
- NMR spectroscopy to determine solution conformation of a ligand.
Main Results:
- Identified divalent GlcNAc ligands with significantly enhanced WGA binding potency (IC50 = 9.8 μM).
- X-ray crystallography revealed simultaneous binding of four divalent ligands to the WGA dimer, bridging all eight binding sites.
- A tetravalent neoglycopeptide showed a 25,500-fold higher potency than GlcNAc, with structural analysis suggesting preorganization for binding.
Conclusions:
- Bridging adjacent protein binding sites with multivalent ligands is an effective strategy for achieving high-affinity interactions.
- Subtle modifications in linker structure can profoundly impact ligand binding affinity.
- The findings provide molecular insights into multivalent binding, aiding the development of novel therapeutics targeting carbohydrate-protein interactions.
Related Concept Videos
Cross-reactivity
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

